Table 2.
Positivity rate by nationality-grouped, age-group, region and symptoms presentation
| Male n (%) | Female n (%) | Total n (%) | |
|
| |||
| Nationality-grouped | |||
|
| |||
| MENA | 12,999 (11.3) | 10,966 (10.9) | 23,965 (11.1) |
|
| |||
| Asian | 9,796 (15.7) | 7,325 (12.9) | 17,121 (13.9) |
|
| |||
| African | 431 (11.3) | 651 (9.4) | 1,082 (10.0) |
|
| |||
| Others | 949 (6.4) | 922 (6.5) | 1,871 (6.4) |
|
| |||
| Age-group | |||
|
| |||
| 0–18 Years | 4,236 (9.8) | 4139 (10.5) | 8,375 (10.1) |
|
| |||
| 19–39 Years | 12,205 (13.5) | 10,323 (11.2) | 22,528 (12.3) |
|
| |||
| 40–59 Years | 6,514 (13.9) | 4,603 (11.1) | 11,117 (12.2) |
|
| |||
| 60+ Years | 1220 (8.9) | 799 (8.4) | 2,019 (8.7) |
|
| |||
| Region | |||
|
| |||
| Central | 8,077 (12.1) | 6,875 (10,3) | 14,952 (11.2) |
|
| |||
| Northern | 8,700 (11.7) | 7,332 (11.1) | 16,032 (11.4) |
|
| |||
| Western | 7,398 (13.3) | 5,657 (11.3) | 13,055 (12.3) |
|
| |||
| Symptoms presentation | |||
|
| |||
| Asymptomatic | 6,108 (4.9) | 5,805 (4.9) | 11,913 (4.9) |
|
| |||
| Symptomatic | 8,308 (18.3) | 8,717 (19.8) | 17,025 (19.0) |
|
| |||